IgG4-Associated Cholangitis

Clinics in Liver Disease

Volumn 17, Issue 2, 2013, Pages 255-268

  Silveira, Marina G ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; Autoimmune pancreatitis; Chronic liver disease; Corticosteroids; Sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTIC ACID; AZATHIOPRINE; BILIRUBIN; BUDESONIDE; GAMMA GLUTAMYLTRANSFERASE; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G4; INTERLEUKIN 10; MERCAPTOPURINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMINOGEN; PREDNISONE; RITUXIMAB;

AUTOIMMUNE PANCREATITIS; AUTOIMMUNITY; BILE DUCT CARCINOMA; BILIARY STENT; CHOLANGITIS; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN G4 ASSOCIATED CHOLANGITIS; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PATHOPHYSIOLOGY; PHLEBITIS; RECOMMENDED DRUG DOSE; REGULATORY T LYMPHOCYTE; RELAPSE; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STEROID THERAPY; TREATMENT RESPONSE;

AUTOIMMUNE DISEASES; CHOLANGITIS; HUMANS; IMMUNOGLOBULIN G; PANCREATITIS; RECURRENCE;

EID: 84875605974     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.11.007     Document Type: Review

References (52)

1. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
2. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N Engl J Med 2012, 366:539-551.
3. Maillette de Buy Wenniger L., Rauws E.A., Beuers U. What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree. Endoscopy 2012, 44:66-73.
4. Kawa S., Okazaki K., Kamisawa T., et al. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2010, 45:355-369.
5. Zhang L., Notohara K., Levy M.J., et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007, 20:23-28.
6. Hardacre J.M., Iacobuzio-Donahue C.A., Sohn T.A., et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003, 237:853-858. [discussion: 8-9].
7. Okazaki K., Kawa S., Kamisawa T., et al. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010, 45:249-265.
8. Kawa S., Ota M., Yoshizawa K., et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002, 122:1264-1269.
9. Park do H., Kim M.H., Oh H.B., et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008, 134:440-446.
10. Frulloni L., Lunardi C., Simone R., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009, 361:2135-2142.
11. Aalberse R.C., Stapel S.O., Schuurman J., et al. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009, 39:469-477.
12. Nirula A., Glaser S.M., Kalled S.L., et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011, 23:119-124.
13. Robinson D.S., Larche M., Durham S.R. Tregs and allergic disease. J Clin Invest 2004, 114:1389-1397.
14. Okazaki K., Uchida K., Koyabu M., et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011, 46:277-288.
15. Miyoshi H., Uchida K., Taniguchi T., et al. Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008, 36:133-140.
16. Zen Y., Fujii T., Harada K., et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007, 45:1538-1546.
17. Nishimori I., Tamakoshi A., Otsuki M., Research Committee on Intractable Diseases of the Pancreas Ministry of Health, Labour, and Welfare of Japan Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007, 42(Suppl 18):6-8.
18. Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715.
19. Toosi M.N., Heathcote J. Pancreatic pseudotumor with sclerosing pancreato-cholangitis: is this a systemic disease?. Am J Gastroenterol 2004, 99:377-382.
20. Takikawa H., Takamori Y., Tanaka A., et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan: presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004, 29:153-159.
21. Mendes F.D., Jorgensen R., Keach J., et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006, 101:2070-2075.
22. Bjornsson E., Chari S.T., Smyrk T.C., et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007, 45:1547-1554.
23. Nakazawa T., Ohara H., Sano H., et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005, 30:20-25.
24. Oseini A.M., Chaiteerakij R., Shire A.M., et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011, 54:940-948.
25. Ghazale A., Chari S.T., Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102:1646-1653.
26. Hirano K., Shiratori Y., Komatsu Y., et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003, 1:453-464.
27. Tabata T., Kamisawa T., Takuma K., et al. Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease. Intern Med 2011, 50:69-75.
28. Vosskuhl K., Negm A.A., Framke T., et al. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy. Endoscopy 2012, 44:48-52.
29. Chari S.T., Smyrk T.C., Levy M.J., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4:1010-1016. [quiz: 934].
30. Kamisawa T., Tu Y., Egawa N., et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?. Abdom Imaging 2009, 34:381-384.
31. Nishino T., Toki F., Oyama H., et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005, 30:76-82.
32. Nishino T., Oyama H., Hashimoto E., et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007, 42:550-559.
33. Kalaitzakis E., Levy M., Kamisawa T., et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011, 9:800-803.e2.
34. Alexander S., Bourke M.J., Williams S.J., et al. Diagnosis of autoimmune pancreatitis with intraductal biliary biopsy and treatment of stricture with serial placement of multiple biliary stents. Gastrointest Endosc 2008, 68:396-399.
35. Smyrk T.C. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol 2011, 23:74-79.
36. Deshpande V., Sainani N.I., Chung R.T., et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol 2009, 22:1287-1295.
37. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pancreas Soc 2002, 17:585-587. [in Japanese].
38. Otsuki M., Chung J.B., Okazaki K., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43:403-408.
39. Ohara H., Okazaki K., Tsubouchi H., et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 2012, 19:536-542.
40. Clendenon J.N., Aranda-Michel J., Krishna M., et al. Recurrent liver failure caused by IgG4 associated cholangitis. Ann Hepatol 2011, 10:562-564.
41. Stathopoulos G., Nourmand A.D., Blackstone M., et al. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor. J Clin Gastroenterol 1995, 21:143-148.
42. Pannala R., Chari S.T. Corticosteroid treatment for autoimmune pancreatitis. Gut 2009, 58:1438-1439.
43. Ghazale A., Chari S.T. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007, 56:1650-1652.
44. Kamisawa T., Shimosegawa T., Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58:1504-1507.
45. Sah R.P., Chari S.T. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep 2012, 14:95-105.
46. Sah R.P., Chari S.T., Pannala R., et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010, 139:140-148. [quiz: e12-3].
47. Church N.I., Pereira S.P., Deheragoda M.G., et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007, 102:2417-2425.
48. Hart P.A., Topazian M.D., Witzig T.E., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2012, [Epub ahead of print].
49. Mannion M., Cron R.Q. Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J 2011, 9:1.
50. Sodikoff J.B., Keilin S.A., Cai Q., et al. Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis. World J Gastroenterol 2012, 18:2287-2290.
51. Topazian M., Witzig T.E., Smyrk T.C., et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008, 6:364-366.
52. Khosroshahi A., Carruthers M.N., Deshpande V., et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine 2012, 91:57-66.